Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006: Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?

Eur Urol. 2021 Apr;79(4):e112. doi: 10.1016/j.eururo.2021.01.013. Epub 2021 Jan 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • B7-H1 Antigen
  • Carcinoma, Renal Cell* / drug therapy
  • Humans
  • Immune Checkpoint Inhibitors
  • Kidney Neoplasms* / drug therapy
  • Urinary Bladder

Substances

  • B7-H1 Antigen
  • Immune Checkpoint Inhibitors